HR 5182 · 114th Congress 2015–2017, ended

Promoting Life-Saving New Therapies for Neonates Act of 2016

Latest action · May 13, 2016 Referred to the Subcommittee on Health.

Progress

Where this bill reached, and when. A stage with no date was not reached; one that failed a vote and later carried shows the date it carried.

  1. IntroducedMay 10, 2016
  2. Passed HouseNot reached
  3. Passed SenateNot reached
  4. To the PresidentNot reached
  5. Became lawNot reached

Summary

Promoting Life-Saving New Therapies for Neonates Act of 2016

This bill amends the Federal Food, Drug, and Cosmetic Act to require the Food and Drug Administration (FDA) to award the sponsor of a new drug or biological product for the treatment of newborns a neonatal drug exclusivity voucher upon approval of the medication. A neonatal drug exclusivity voucher is a transferable voucher for a one-year extension of all existing patents and marketing exclusivities for a brand name medication. For a sponsor to be eligible for a voucher, the new medication must: (1) treat a condition identified in the Priority List of Critical Needs for Neonates required under this bill, and (2) have been studied in newborns.

A voucher may be revoked if the new medication is not marketed in the United States within one year of approval.

A voucher may not be used: (1) to extend the marketing exclusivity period for a drug for which the FDA requires an assessment of the safety and effectiveness in newborns, or (2) on the same product as a priority review voucher.

A sponsor intending to use a voucher must notify the FDA at least 15 months before the expiration of the patents or exclusivity to be extended.

The Government Accountability Office must study the effectiveness of this voucher program.

Cosponsors 33

Members who signed on, in the order they did. Signatures ran from May 10, 2016 to Sep 28, 2016; 1 is an original cosponsor, there from the day it was introduced.

SeatCosponsorSigned on
D-NMBen Ray LujánOriginalMay 10, 2016
D-NCAlma S. AdamsMay 23, 2016
D-VAGerald E. ConnollyJun 8, 2016
D-NJBill Pascrell, Jr.Jun 10, 2016
R-MEBruce PoliquinJun 10, 2016
D-TXMarc A. VeaseyJun 10, 2016
R-KYBrett GuthrieJun 16, 2016
D-NJDonald NorcrossJun 16, 2016
D-CAPete AguilarJun 16, 2016
D-AZRuben GallegoJun 16, 2016
D-NJAlbio SiresJul 5, 2016
D-NYKathleen M. RiceJul 5, 2016
D-FLPatrick MurphyJul 5, 2016
R-WISean P. DuffyJul 5, 2016
R-WVEvan H. JenkinsJul 6, 2016
R-NJLeonard LanceJul 6, 2016
R-WVAlexander X. MooneyJul 12, 2016
D-NEBrad AshfordJul 12, 2016
D-CAGrace F. NapolitanoJul 12, 2016
D-MASeth MoultonJul 12, 2016
D-ILBobby L. RushJul 13, 2016
R-FLGus M. BilirakisJul 13, 2016
R-NYPeter T. KingJul 13, 2016
R-MIMike BishopJul 14, 2016
D-WADerek KilmerSep 6, 2016
D-NYSteve IsraelSep 6, 2016
D-CATony CárdenasSep 6, 2016
R-PAMike KellySep 20, 2016
R-ILRobert J. DoldSep 20, 2016
D-CAScott H. PetersSep 22, 2016
D-IADavid LoebsackSep 27, 2016
D-NCDavid E. PriceSep 28, 2016
R-MNErik PaulsenSep 28, 2016

Committees 1

Where it was sent and what each committee and subcommittee did with it, in order.

ChamberCommitteeWhat it did
HouseEnergy and Commerce Committee
Referred May 10, 2016
Health Subcommittee
Referred May 13, 2016

Actions 3

Everything that happened, newest first.

  1. May 13, 2016Referred to the Subcommittee on Health.
  2. May 10, 2016Introduced in House
  3. May 10, 2016Referred to the House Committee on Energy and Commerce.

Research

What has been written about this bill: committee reports, cost estimates, the sponsor’s authority statement, printed hearings and the Congressional Research Service’s work.

Constitutional authority

Congress has the power to enact this legislation pursuant to the following: Article 1, Section 8, Clause 18 of the Constitution, which states ``To make all Laws which shall be necessary and proper in the Government of the United States or in any Department or Officer thereof.''

The sponsor’s statement, as printed in the Congressional Record, vol. 162, no. 73, May 10, 2016, page H2214.

Related bills 2

Companion bills and other measures the record links to this one.

BillTitleRelationshipLatest action
S 2041Promoting Life-Saving New Therapies for Neonates Act of 2015Related billSep 16, 2015
HR 2641Promoting Life-Saving New Therapies for Neonates Act of 2017Reintroduced BillMay 26, 2017

Titles 2

Every title it has carried, official and short, at each stage.

Official Title as Introduced
To promote the development of safe drugs for neonates.
Short Titles as Introduced
Promoting Life-Saving New Therapies for Neonates Act of 2016

Subjects

Assigned by the Library of Congress. Policy area: Health.

Text 1

Each version as it was printed, newest first.

  1. May 10, 2016Introduced in House

Support LegiList

This page is free, carries no paywall, and is built and maintained by one person. If the record here is useful to you, a few dollars keeps it going.

Processed by Stripe in a separate window. LegiList never sees card details. Other amounts

Everything here is as published by Congress: the summary is the Congressional Research Service's, the action wording is the clerks', and the subjects are the Library of Congress's. How far it got is read from the actions themselves, taking the most recent one of each kind, so a bill that failed a vote and later passed is shown as having passed. Records come from this bill on Congress.gov and govinfo.gov; cost estimates are the Congressional Budget Office's, and the hearings are the printed hearings GovInfo publishes, which can appear months after the hearing.